Selumetinib
Medication
>
Selumetinib, sold under the brand name Koselugo, is a medication for the treatment of children, two years of age and older, with neurofibromatosis type I, a genetic disorder of the nervous system causing tumors to grow on nerves. It is taken by... Wikipedia
AHFS/Drugs.com: Monograph
ATC code: L01EE04 (WHO)
Elimination half-life: 5.3–7.2 hrs
Excretion: Bile duct
Other names: AZD6244, ARRY-142886
Pregnancy category: : AU: D; Contraindicated;